These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12826994)

  • 1. Hypothermia in a hemodialysis patient treated with olanzapine monotherapy.
    Fukunishi I; Sato Y; Kino K; Shirai T; Kitaoka T
    J Clin Psychopharmacol; 2003 Jun; 23(3):314. PubMed ID: 12826994
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine.
    Hägg S; Mjörndal T; Lindqvist L
    J Clin Psychopharmacol; 2001 Feb; 21(1):113-5. PubMed ID: 11199936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon].
    Joye F; Orrillard M; Marion F; Michoux I; Parisot R
    Ann Fr Anesth Reanim; 1999 Jun; 18(6):686-90. PubMed ID: 10464538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia associated with olanzapine monotherapy.
    Ananth J; Kenan J
    J Clin Psychiatry; 1999 Dec; 60(12):870. PubMed ID: 10665640
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine-induced urinary incontinence: treatment with ephedrine.
    Vernon LT; Fuller MA; Hattab H; Varnes KM
    J Clin Psychiatry; 2000 Aug; 61(8):601-2. PubMed ID: 10982206
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder.
    Marusic A; Farmer A
    Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11270368
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
    Oerther S; Ahlenius S
    J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia in patients with schizophrenia who are treated with olanzapine.
    Lindenmayer JP; Smith RC; Singh A; Parker B; Chou E; Kotsaftis A
    J Clin Psychopharmacol; 2001 Jun; 21(3):351-3. PubMed ID: 11386505
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine and pancreatitis.
    Hagger R; Brown C; Hurley P
    Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11102343
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine-induced agranulocytosis: a case report and review of the literature.
    Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine/risperidone and diabetes risk.
    Lee DW; Fowler RB
    J Clin Psychiatry; 2003 Jul; 64(7):847-8; author reply 848. PubMed ID: 12934988
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine-induced galactorrhea.
    Licht RW; Arngrim T; Cristensen H
    Psychopharmacology (Berl); 2002 Jun; 162(1):94-5. PubMed ID: 12141277
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid onset of tardive dyskinesia in Huntington disease with olanzapine.
    Benazzi F
    J Clin Psychopharmacol; 2002 Aug; 22(4):438-9. PubMed ID: 12172349
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine-induced respiratory failure.
    Mouallem M; Wolf I
    Am J Geriatr Psychiatry; 2001; 9(3):304-5. PubMed ID: 11481140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hepatocellular-cholestatic liver injury after olanzapine therapy.
    Jadallah KA; Limauro DL; Colatrella AM
    Ann Intern Med; 2003 Feb; 138(4):357-8. PubMed ID: 12585842
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute dystonia with olanzapine.
    Landry P; Cournoyer J
    J Clin Psychiatry; 1998 Jul; 59(7):384. PubMed ID: 9714272
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine: weight gain and therapeutic efficacy.
    Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B
    J Clin Psychopharmacol; 1999 Jun; 19(3):273-5. PubMed ID: 10350036
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine induced "typical" neuroleptic malignant syndrome.
    Goveas JS; Hermida A
    J Clin Psychopharmacol; 2003 Feb; 23(1):101-2. PubMed ID: 12544383
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine-induced priapism.
    Songer DA; Barclay JC
    Am J Psychiatry; 2001 Dec; 158(12):2087-8. PubMed ID: 11729037
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine can worsen parkinsonism.
    Jiménez-Jiménez FJ; Tallón-Barranco A; Ortí-Pareja M; Zurdo M; Porta J; Molina JA
    Neurology; 1998 Apr; 50(4):1183-4. PubMed ID: 9566425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.